Chris de Graaf
Corporate Officer/Principal chez Beacon Biosignals, Inc.
Profil
Chris de Graaf currently works at Beacon Biosignals, Inc., as Site Reliability Engineer.
Postes actifs de Chris de Graaf
| Sociétés | Poste | Début |
|---|---|---|
Beacon Biosignals, Inc.
 Beacon Biosignals, Inc. Packaged SoftwareTechnology Services Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Beacon Biosignals, Inc.
Beacon Biosignals, Inc. Packaged SoftwareTechnology Services Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019. | Technology Services |
